Potential benefits of ticagrelor plus aspirin in Chinese patients with stable coronary artery disease and diabetes

被引：0
|
作者：
Sun, W. [1 ]
Yan, B. [1 ]
机构：
[1] Chinese Univ Hong Kong, Hong Kong, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1218 / 1218
页数：1
相关论文
共 50 条
  • [1] Cost-utility of ticagrelor plus aspirin in diabetic patients with stable coronary artery disease
    Wu, Bin
    Shi, Lizheng
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (06) : 529 - 538
  • [2] Ticagrelor in Patients with Stable Coronary Disease and Diabetes
    Steg, P. Gabriel
    Bhatt, Deepak L.
    Simon, Tabassome
    Fox, Kim
    Mehta, Shamir R.
    Harrington, Robert A.
    Held, Claes
    Andersson, Marielle
    Himmelmann, Anders
    Ridderstrale, Wilhelm
    Leonsson-Zachrisson, Maria
    Liu, Yuyin
    Opolski, Grzegorz
    Zateyshchikov, Dmitry
    Ge, Junbo
    Nicolau, Jose C.
    Corbalan, Ramon
    Cornel, Jan H.
    Widimsky, Petr
    Leiter, Lawrence A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (14): : 1309 - 1320
  • [3] Pharmacodynamics, pharmacokinetics, and safety of ticagrelor in Chinese patients with stable coronary artery disease
    Li, Haiyan
    Guo, Jingchuan
    Carlson, Glenn F.
    Teng, Renli
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (02) : 352 - 361
  • [4] Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Coronary Artery Disease
    Husted, Steen E.
    Gurbel, Paul
    Storey, Robert F.
    Bliden, Kevin
    Hoimark, Lene
    Antonino, Mark J.
    Mahla, Elisabeth
    Tantry, Udaya
    Butler, Kathleen
    Wei, Cheryl
    Teng, Renli
    CIRCULATION, 2009, 120 (18) : S1102 - S1102
  • [5] Aspirin desensitisation for Chinese patients with coronary artery disease
    Lee, Joe K. T.
    Tsui, K. L.
    Cheung, C. Y.
    Chau, C. H.
    Chan, H. L.
    Wu, K. L.
    Cheung, Gary S. H.
    Choi, M. C.
    Chan, K. K.
    Li, S. K.
    HONG KONG MEDICAL JOURNAL, 2013, 19 (03) : 207 - 213
  • [6] Ticagrelor or Aspirin After Coronary Artery Bypass in Patients With Chronic Kidney Disease
    Sandner, Sigrid E.
    Schunkert, Heribert
    Kastrati, Adnan
    Milojevic, Milan
    Boning, Andreas
    Zimpfer, Daniel
    Zellmer, Stephan
    Wiedemann, Dominik
    Laufer, Gunther
    von Scheidt, Moritz
    ANNALS OF THORACIC SURGERY, 2022, 113 (02): : 554 - 562
  • [7] The Effect of Ticagrelor on Cardiopulmonary Function in Patients With Stable Coronary Artery Disease
    Storey, Robert F.
    Bliden, Kevin
    Patil, Shankar B.
    Karunakaran, Arun
    Ecob, Rosemary
    Butler, Kathleen
    Teng, Renli
    Gurbel, Paul
    CIRCULATION, 2009, 120 (18) : S1145 - S1145
  • [8] Pharmacological Resistance to Aspirin In Patients with Stable Coronary Artery Disease
    Chadha, Davinder S.
    Budha, Sumana
    Prasad, Jaya, V
    Shet, Arun S.
    BLOOD, 2010, 116 (21) : 479 - 479
  • [9] Cost-effectiveness of rivaroxaban plus aspirin versus aspirin alone in patients with stable coronary artery disease or peripheral artery disease: a systematic review
    Arabloo, Jalal
    Rezaei, Mohammad Ali
    Makhtoumi, Vahid
    Sadiani, Zahra Mollaei
    Rezapour, Aziz
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2025, 81 (02) : 279 - 290
  • [10] Pharmacodynamics, pharmacokinetics and safety of ticagrelor in Asian patients with stable coronary artery disease
    Hiasa Y.
    Teng R.
    Emanuelsson H.
    Cardiovascular Intervention and Therapeutics, 2014, 29 (4) : 324 - 333
12345